Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New measures for registering imported Keeshonds
PHPT is a genetic disorder caused by the excessive secretion of parathyroid hormone into the blood.
Imported dogs must soon be tested for primary hyperparathyroidism.

The Kennel Club has announced new measures for registering the progeny of imported Keeshonds.

Under the new measures, all imported Keeshonds, or overseas dogs being used in a UK breeding programme, must be tested for primary hyperparathyroidism (PHPT) before registration of their progeny is accepted. 

Likewise, any litters produced via artificial insemination (AI) must be tested before registration to avoid wasting sperm samples from deceased dogs and the potential loss of genes.

The restrictions, which have been agreed following consultation with the Keeshond Breed Health Coordinator, come into force on 1 January 2021. 

Dr Tom Lewis, genetics & research manager at The Kennel Club, said: “The Kennel Club constantly reviews DNA testing schemes in conjunction with breed clubs to ensure that breeders are supported with resources which help them to make responsible breeding decisions. 

“We work alongside breed clubs and breed health coordinators in a collaborative effort to improve the health of pedigree dogs and are happy to accommodate a breed's request to tailor restrictions for a DNA test, for breeds which fit a number of suitable criteria. A formal request from the breed health coordinator or a majority request from the breed clubs is normally required to do this.” 

PHPT is a genetic disorder caused by the excessive secretion of parathyroid hormone into the blood. This excess hormone causes calcium levels to rise above normal levels, leading to muscle weakness, unitary tract problems, weight loss and vomiting, but signs are often not evident until later in the dog's life.

Breed Health Coordinator, Anji Marfleet, commented: “The breed are excited that the proposal has been accepted, which will lessen the risk of untested dogs bringing PHPT into the UK population. It will also benefit breeders to raise the profile of health testing, and in particular awareness for this condition. 

“The Keeshond is a small breed so the ability to use dogs from overseas, but also be aware of their hereditary status, will ensure we can maintain the gene pool for our breed and continue to breed healthy dogs. The breed are also keen to monitor and research PHPT further in the UK population, and will continue to engage in research opportunities surrounding this disease.”

Become a member or log in to add this story to your CPD history

Building Great Workplaces webinars return

News Story 1
 BVA has announced a new series of its Building Great Workplaces lunchtime webinars.

Launching from 16 July, the sessions will explore patient safety, motivation, client communication and more.

Its first webinar, exploring neurodiversity in the workplace, will take place at 1pm on Thursday, 16 July. It will feature guest speakers from The Vet Project, a group which supports neurodiversity in veterinary environments.

The following three webinars take place in September, October and November.

Booking is open on the BVA website 

Click here for more...
News Shorts
New form for online veterinary medicines retailers

The Veterinary Medicines Directorate (VMD) has produced a new online form for retailers wishing to sell veterinary medicines on the internet.

The form replace the previous Word version and is part of the VMD's ongoing commitment to digitise its processes. Anyone retailing prescription medicines online, including POM-V, POM-VPS and NFA-VPS categories, is lawfully required to register with the VMD before trading.

The change only applies to new applicants. Retailers already listed on the VMD's Register of Online Retailers or registered under the Accredited Internet Retailer Scheme (AIRS) do not need to do anything.